Freedom Broker maintains Pfizer at Buy, raises price target to $34 from $33
Freedom Broker maintained Pfizer at Buy and raised its price target to $34 from $33, a 3.0% increase.The price target implies an upside of 15.7% from the Nov 6 close of $29.39.Recent analyst actions on PfizerAcross the five most recent analyst notes published on Pfizer over the past 30 days, price…
Freedom Broker maintained Pfizer at Buy and raised its price target to $34 from $33, a 3.0% increase.The price target implies an upside of 15.7% from the Nov 6 close of $29.39.Recent analyst actions on PfizerAcross the five most recent analyst notes published on Pfizer over the past 30 days, price…
What's Your Reaction?
